Chemical exposures during pregnancy can have a profound and life-long impact on human health. Because of the omnipresence of chemicals in our daily life, there is continuous contact with chemicals in food, water, air, and consumer products. Consequently, human biomonitoring studies show that pregnant women around the globe are exposed to a variety of chemicals. In this review we provide a summary of current data on maternal and fetal exposure, as well as health consequences from these exposures. We review several chemical classes, including polychlorinated biphenyls, perfluoroalkyl substances, polybrominated diphenyl ethers, phenols, phthalates, pesticides, and metals. Additionally, we discuss environmental disparities and vulnerable populations, and future research directions. We conclude by providing some recommendations for prevention of chemical exposure and its adverse reproductive health consequences. (Fertil Steril Ò 2016;106:905-29.
S
cientific evidence has shown the adverse impacts of exposure to toxic environmental chemicals to human reproduction (1) . Chemical exposures, especially during critical and sensitive windows of development such as pregnancy, can lead to a myriad of health consequences that can manifest across individuals' lifespan and potentially be transmitted to future generations (1, 2) . Chemical exposures that occur during pregnancy can cross the placenta and can accumulate in the fetus (3) . Accordingly, the next generations are born ''prepolluted'' (4) owing to these preconception and prebirth exposures. Preventing harmful exposures to environmental chemicals is, therefore, a priority for reproductive health professionals around the world (5) .
Industrial chemicals are present in our daily life and are ubiquitous in food, water, air, and consumer products. World chemical manufacturing has grown rapidly over the past few decades (6, 7) , with a projected 3.4% annual rate in production increase until 2030 (7) . Among the estimated 70,000-100,000 commercially available chemicals, almost 5,000 of them are produced in volumes exceeding 1 million tons per year (8) . In the United States, the total reported production volume (domestically manufactured and imported) of industrial chemicals in 2012 was 9.5 trillion pounds (4.31 trillion kg)-equivalent to more than 30,000 pounds (13,000 kg) for every American (5, 9). As of 2016 more than 65,000 chemical substances are listed for use by the US Environmental Protection Agency (10) . Approximately 3,000 of these chemicals have annual production and importation above 1 million pounds (11) . Unlike pharmaceu-ticals that require extensive in vitro and in vivo toxicity testing as well as human experimental studies before entering the marketplace and clinic, existing and new synthesized industrial chemicals currently can enter the marketplace, homes, schools, workplaces, and communities with only limited or even no assessment on their reproductive or other related toxic effects (12, 13) . Recently (June 2016), President Obama signed the Frank R. Lautenberg Chemical Safety for the 21st Century Act, an amendment to the Toxic Substances Control Act (TSCA), which is the main law by which the government oversees industrial chemicals.
While there are significant changes, the law still does not require minimum set of data to be produced by manufacturers for new or existing chemicals, and its effectiveness remains to be evaluated. Further, there are not comprehensive data on where chemicals are used, so it is difficult to identify sources of exposures and the extent of exposures in the population. There are some data sources that allow characterization of certain exposures, such as air pollution monitoring, some monitoring of fish, and some portion of the water and food supply (14) . In the United States there is a national biomonitoring program run by the US Center for Disease Control and Prevention (CDC) using the National Health and Nutrition Examination Survey (NHANES), which has increased the number of chemicals biomonitored over the past 15 years ( Fig. 1) (15, 16) .
Although we have made great progress in understanding the importance of chemicals in reproductive health and understanding exposures to pregnancy, we still have yet to comprehensively understand the full scope of the exposures and outcomes that may affect reproductive health. Understanding exposures is critical to both identify potential health risks and identify opportunities for intervention and prevention of harmful chemical exposures. It is being increasingly recognized in numerous initiatives, including the Exposome (17) , Precision Medicine Initiative (18) , Genes, Environment and Health Initiative (19) , and Children's Health Exposure Analysis Resource (20) . Thus, using illustrative examples, this article aims to review the current evidence on environmental chemical exposures, including synthetic chemicals and metals, in pregnant women. We first provide an updated view on the relationship between environmental chemical exposure during pregnancy and potential adverse health consequences. We then summarize the current knowledge on the maternal body burden and fetal exposure to different environmental chemicals. After discussion on environmental disparities and future research directions, we conclude the article with recommendations for prevention of chemical exposure and its adverse health consequences.
TABLE 1
Examples of exposure sources and pathways and selected health impacts of prenatal exposure to environmental contaminants.
Chemical
Exposure sources and pathways Selected health impact (reproduction, poor birth outcome, neurodevelopment, and cancer) PCBs Used as industrial insulators and lubricants; banned in the 1970s, but persistent in the aquatic and terrestrial food chains, which results in exposure by ingestion Decreased semen quality (21) Low birth weight (22) Development of attention deficit-hyperactivity disorderassociated behavior (23) Reduced intelligence quotient (24) PFAS Widely used man-made organofluorine compounds with many diverse industrial and consumer product applications; examples are PFOS and PFOA, which are used in the manufacture of nonstick Teflon and other trademark cookware products and in food-contact packaging to provide grease, oil, and water resistance to plates, food containers, bags, and wraps that come into contact with food; persist in the environment; occupational exposure to workers and general population exposure by inhalation, ingestion, and dermal contact Pregnancy-induced hypertension and preeclampsia (25) Reduced birthweight (26, 27) Reduced fetal growth (28 related affects, adverse pregnancy outcomes, and adverse health effects in childhood, such as neurodevelopmental effects (Table 1) . A key adverse health impact of concern to human reproduction and development is the endocrine-disrupting property of many chemicals, particularly affecting hormones that are critical to proper development. These chemicals include polychlorinated biphenyls (PCBs), perfluoroalkyl substances (PFAS), polybrominated diphenyl ethers (PBDEs), bisphenol A (BPA), some current-use pesticides, metals, and others (83) . Exposure to environmental contaminants, especially during ''critical'' and ''sensitive'' periods of development such as during pregnancy, can heighten their potential impact. For example, prenatal exposure to lead and methyl mercury can lead to developmental neurotoxicity of the fetus (Table 1 ) (84) . Sometimes, such negative health impact can be transgenerational and becomes apparent only decades after the initial exposure, as in the case of the drug diethylstilbestrol, a potent synthetic estrogen (5). The daughters of pregnant women who took diethylstilbestrol were found to have higher risks of infertility, poor pregnancy outcomes, and breast cancer (85) , whereas the sons of these women have increased the risk of hypospadias (86, 87) . Such exposures during a window of vulnerability, even of small quantity, may trigger adverse health consequences that can manifest across the lifespan of individuals and generations (5) . Despite these previous studies and discoveries, there is a paucity of studies on the effects of chemicals and reproductive outcomes, especially with regard to the number of chemicals and their potential harm.
MATERNAL CHEMICAL BODY BURDEN
Pregnant women can be exposed to environmental chemicals in food, water, air, and consumer products, as well as soil and dust; such exposure can happen via multiple pathways, including ingestion, inhalation, and dermal contact ( (89) . As illustrations, we have collected information on chemical concentrations measured in biomonitoring of pregnant women from more than 30 countries around the world on the most commonly measured chemicals or their metabolites (Tables 2-8). We focused on studies that have mothers' biospecimens taken during pregnancy or at delivery and cord blood samples collected at delivery unless otherwise noted, and on studies published in the past 5 years for heavy metals because another study has summarized blood cadmium, lead, and mercury levels from studies published from 2000 onward (201) . We focus this review on common classes of chemicals and organize the following discussion according to chemical properties: persistent and bioaccumulative halogenated chemicals, less persistent and bioaccumulative chemicals, pesticides, and metals and organometallic chemicals. For each class of chemicals, we first briefly summarize the exposure sources and its health effect and then discuss its concentrations from biomonitoring studies. 
Persistent and Bioaccumulative Halogenated Chemicals
Many chemicals measured and found prevalently in pregnant women are persistent and bioaccumulative halogenated chemicals such as PCBs, PFAS, PBDEs, and organochlorine pesticides (OCPs) such as dichlorodiphenyltrichloroethane (DDT). Because of their chemical properties they persist and can bioaccumulate up the food chain. Thus, they can remain in the environment and can be a source of exposure and pose risk to the health of humans and wildlife for many years. Even after their production and use are discontinued, it may take many years before their concentrations have sufficiently declined to minimal levels that are of less concern to human health (244) . For example, despite being banned in the United States after 1979, several PCBs (118, 138 and 158, 153, 180) were still detected in nearly 100% of pregnant women from the NHANES 2003-2004 study (89) . Polychlorinated biphenyls had once been used as industrial insulators and lubricants and have been shown to link to low birth weight (22) and poorer neurodevelopment outcomes (23) ( Table 1 ). Because they persist in the aquatic and terrestrial food chains, high levels of PCBs were documented among Inuit pregnant women living in Nunavik (Arctic Quebec, Canada), owing to high consumption of fish and marine mammals (94) . Fortunately, the maternal concentration of PCB-153, the main contributor of the overall PCB level, has been declining over the years, though with some variability across countries (Table 2) . Perfluoroalkyl substances, especially perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA), were used in the manufacture of nonstick cookware products and in foodcontact packaging and have been linked to reduced birth weight (26, 27) and fetal growth (28) ( Table 1 ). They are detected in the serum of 90%-100% of pregnant women (3). One study examined the temporal changes in the levels of PFAS among California women over the past 50 years and found a significant drop of PFOS level from the 1960s to 2009, which is consistent with the phase-out of the perfluorooctyl manufacturing practice in the United States in 2002 (245) . The   TABLE 3 Example studies of concentration of selected PFAS in pregnant women, by location and study years. (246) . The increasing blood levels of perfluorononanoic acid and perfluorodecanoic acid most likely reflect the increased use of their precursors-fluorotelomer chemicals-in commercial products after banning PFOS (247) . Perfluorobutane sulfonate-a replacement for PFOS-based chemicals used as stain repellents-is also shown to increase in human blood, with levels doubling every 6 years among Swedish women from 1996 to 2010 (246) . Polybrominated diphenyl ethers are a newer class of persistent chemicals that have been used as flame retardants in furniture, textiles, carpeting, electronics, and plastics and are linked to impaired neurodevelopment and poorer motor, cognitive, and behavioral performance at school age (30, 31) ( Table 1) . Here we present data for the sum of different PBDE congeners and 2,2 0 ,4,4 0 -tetrabromodiphenyl ether (BDE-47), one of the major congeners in the commercial mixture because it represents the most often found PBDE (Table 4) . Polybrominated diphenyl ethers (e.g., BDE-47) have been measured in populations around the globe (Table 4) . BDE-47 is the most abundant PBDE detected in the serum of pregnant women from North America, Europe, and most places around the world, with exceptions in Denmark and China, where the most abundant PBDE is BDE-209 (125) or BDE-153 (115), respectively. The concentration of BDE-47 and sum of PBDEs are also much higher among North American pregnant women compared with women from the rest of the world. The highest maternal serum concentration of BDE-47 was reported among pregnant women from Northern and Central California (134) , which was in part due to regulatory standards in California requiring use of flame retardant chemicals in furniture (248) . Levels of PBDEs have been shown to decline as a result of them being banned and phased out and the changed regulatory standard for flame retardants (249, 250) .
Less Persistent and Bioaccumulative Chemicals
Many chemicals are nonpersistent and tend to be rapidly metabolized and eliminated, with half-lives in the human body within 24 hours. Two examples of these chemicals that are widely reported in biomonitoring studies are phenols, a type of carbolic acid and aromatic compound including BPA, triclosan, and parabens (3, 251) , and phthalates (252) . In contrast to the persistent chemicals such as PFAS, for which maternal concentrations across pregnancy are highly correlated (123) , only low to moderate correlations were found between multiple measurements taken over pregnancy for less persistent chemicals such as BPA (156, 161, 166) and phthalate metabolites (161, 253) . Thus, multiple measurements of these chemicals across pregnancy, particularly for studies of small sample size, are recommended (161, 254) . Phenols are (255) widely found in consumer products, packaging, and cosmetic products and are also used in foods and drugs (Table 1) . Bisphenol A is a female reproductive toxicant (32) and has been linked to adverse hormonal and behavioral outcomes in childhood (Table 1 ). There is sufficient nonhuman evidence of an association between triclosan exposure and thyroxine concentration decrements, and triclosan is possibly toxic to reproductive and developmental health (37) . Research also suggests that parabens have estrogenic activity (39) . Detectable levels across multiple populations of these types of chemicals indicate recent and/or continuous exposure to the chemicals, and have been shown for BPA (Table 5) , triclosan (Table 5) , and three types of parabens (Table 6 ). Comparable BPA concentrations were found across different studies and geographic locations (Table 5) . Fewer studies have documented the concentration of triclosan and parabens. There are variabilities in maternal triclosan concentration across studies (Table 6 ). Methyl paraben had a much higher concentration than butyl paraben and propyl paraben, despite the small number of studies (Table 6) .
Phthalates are used in a variety of consumer goods, such as medical devices, cleaning and building materials, personal care products, and cosmetics, and have been linked to shortened gestational age (40) and impaired neurodevelopment in girls (256) ( Table 1) . Phthalate metabolites are detected in more than 90% of the maternal urine samples during pregnancy among North American or European populations (3). Yet there are variations in monoethyl phthalate (MEP) levels across different studies and populations (Table 7) .
Pesticides
Pesticides have been used to control a variety of pests, such as insects, weeds, rats and mice, bacteria and mold, and more, and are applied in agricultural, community, and household settings. Different pesticides have been associated with a range of reproductive and developmental outcomes, including poorer birth outcomes, impaired cognitive development and neurodevelopment, and childhood cancers (Table 1) . Among pesticides, OCPs such as hexachlorobenzene, DDT, chlordane, and hexachlorocyclohexane have been more widely studied, owing to their earlier use and their persistent and bioaccumulative nature and endocrine-disrupting properties, as well as their adverse health effects (3, 257) . Despite being banned in the United States in the 1970s, some OCPs are still detected in US pregnant women (89) . Dichlorodiphenyltrichloroethane is still used in some places TABLE 8 Continued.
Location around the world, most notably for controlling mosquitoborne diseases, including malaria. As expected, in a study examining the regional difference of DDT exposure in South Africa, the authors found that levels of DDT isomers in plasma of delivering women were the highest in the endemic malaria sites where indoor residual spraying with DDT was taking place, among mining, urban, industrial, Atlantic, and rural sites (258) . Women living in Latin America and other regions that use OCPs also have relatively higher maternal OCP levels (99, 259, 260) . Current-use pesticides, characterized by shorter half-lives and chemical properties that do not promote bioaccumulation in sediments or organisms, are used to control a wide range of pests and in a variety of applications. For example, 2,4-dichlorophenol, 2,5-dichlorophenol, and 1-naphthol have been detected in more than 50% of pregnant women from the Salinas Valley in California (agricultural region) and with higher median concentrations than that from a US nationwide sample (NHANES study) (261).
Metals and Organometallic Chemicals
Cadmium, lead, and mercury are three metals that have been widely used in a variety of applications over the past 50 years. They are also among the most well-studied industrial pollutants and have been found collectively to have a number of adverse reproductive and developmental effects. Cadmiums are used in batteries, pigments, metal coatings, and plastics and have been found to alter epigenetic signatures in the DNA of both the placenta and newborns (45), reduce intelligence quotient (46) , and increase risk of emotional problems in boys (47) ( Table 1) . It can accumulate in liver and kidney, has a long half-life of 5-40 years in the body (262) , and has been detected in both maternal and cord blood (Table 8) .
Lead was widely used in gas, paint, water pipes, and other applications. Although lead use in many applications has been banned for several decades, exposure can still occur in older homes where lead-based paints were used, and in or on toys, costume jewelry, and water pipes. Lead has been linked to alterations in genomic methylation (48) and impaired neurodevelopment (49, 50) (Table 1) . In human adults, approximately 94% of the total body burden of lead is found in the bones. During pregnancy the mobilization of bone lead will increase, which contributes to 10%-88% of the lead in blood in pregnant women (263) . Environmental policies, including removing lead from gasoline, paint, and water pipes, have led to significant reductions in blood lead levels in the United States. The median level of blood lead among pregnant women from the United States tends to be lower than in women from the rest of the world (Table 8 ) (201) . Similarly, a gradual reduction in blood lead levels over time has been reported in pregnant women from the United Kingdom (UK), which is in accordance with banning lead in petrol and paint, replacing lead water pipes, and reducing cigarette smoking in the UK (201) .
Mercury, which comes primarily from coal-burning power plants, combustion of waste, industrial processes that use mercury, and from natural sources such as volcanoes (14), usually gets into the human body through consumption of contaminated seafood or fresh water fish and can negatively affect cognitive performance and neurodevelopment (Table 1) . Maternal blood mercury levels can vary across geographic areas and populations (Table 8) . Populations with high fish consumption tend to have higher maternal blood mercury levels during pregnancy, for example pregnant women in Japan (216, 241) and Faroe Islands (200) and the Inuit population in Nunavik (Arctic Quebec, Canada) (189) .
Challenges of Biomonitoring Studies
Biomonitoring studies, despite their usefulness, have their own challenges. Cautions should be taken when trying to compare maternal blood levels across biomonitoring studies, owing to differences in sample size, sample preparation and analytical techniques, study period, and gestational ages at which the blood is drawn (201) . Additionally, chemical levels measured in biomonitoring studies do not provide information about the sources of exposure but are the sum of exposures through multiple pathways. Environmental monitoring (e.g., air, water, and soil) studies, on the other hand, can provide useful information on exposure sources identification, which is critical for prevention.
PLACENTAL TRANSFER AND FETAL BURDEN
Fetal chemical exposures result from maternal body burden of chemicals during pregnancy due to placental transfer. However, fetal exposure is difficult to measure directly and thus is usually achieved by measuring chemicals in maternal matrices as a surrogate, or by measuring chemicals in cord blood, placental tissue, amniotic fluid, or neonatal meconium (2, 264) . The pattern of placental transfer is determined by the specific structure, chemical composition, molecular weight, and relative persistence of xenobiotic chemicals (2) . Past literature has documented that most classes of environmental chemicals can cross into the fetal environment. These chemicals include metals, PCBs, PFAS, PBDEs, pesticides, phenols, and phthalates.
Some xenobiotic chemicals can bioaccumulate in the fetus and result in higher fetal exposure than maternal exposure, whereas others are transferred in equal or less proportion (2, 3) . For example, studies have consistently found higher mercury concentration in cord blood than in maternal blood across different populations, the former being 1.5 to 3 times that of the latter (190, 207, 214, 221, 236, 241) . Polychlorinated biphenyls are widely detected in cord blood (107, 114) . Nearly all PCBs are found in higher levels in maternal than cord serum (265) , with the exception of only a few congeners (266) . One recent study suggested that lower chlorinated PCB congeners have a higher maternal-fetal transfer rate compared with higher chlorinated congeners (267) , but this pattern is not supported by a systematic review and other studies (265, 268, 269) . As PCB congener molecular weight (267, 269) or lipophilicity (269) increase, placental transfer decreases. However, lipophilicity does not always predict bioaccumulation. Polybrominated diphenyl ethers are lipophilic and also frequently detected in cord blood (3) . Though the degree of bromination was suggested to influence placental transport, no apparent trend in ratios of cord:maternal concentration (>1 meaning concentration higher in cord blood than in maternal blood) was observed (265) . The central estimates of this ratio also varied for the same PBDE congener across studies and depended on the measure (i.e., wet-weight basis or lipid-weight basis) (265) . Organochlorine pesticides, similar to PBDEs, are also lipophilic chemicals and have been detected in placenta tissues (270) and cord serum (271) (272) (273) (274) . The majority of the studies included in a recent review reported central estimates of cord:maternal to be near or below 1 for most OCPs, on the basis of both wet-weight and lipid-adjusted concentrations (265) .
Other chemicals tend to more evenly distribute between maternal-fetal compartments. For example, phenols, phthalates, and phthalate metabolites can cross the placenta, but evidence suggests that they do not accumulate in the fetus (3). Studies in both human (275) and rats (276) indicated that both active BPA and its inactive form can cross the placenta into the fetus, where most of the active form remains active and some of the inactive forms can be converted to the active form. Moreover, certain forms of the chemicals can distribute disproportionally in maternal vs. fetal environment, owing to immaturity of enzymes that conjugate or metabolize these chemicals. For example, levels of BPA and BPA in sulfate form were two to three times higher than levels of BPA in glucuronide form in cord sera collected during mid-gestation, possibly owing to immaturity of the glucuronidation conjugation enzymes (163) . Among the few human studies that have compared concentrations of BPA in fetal and maternal blood sera, the reported mean BPA level is lower in fetal serum in some studies (171, (277) (278) (279) but higher in others (280) . Phthalate levels in cord blood or newborns' urine were found to be similar to or lower than that in maternal blood or urine, respectively (281, 282) . Except for BPA, evidence is limited on placental transfer characteristics of triclosan, parabens, phthalates, and phthalate metabolites, and the transfer patterns of these chemicals need further investigation.
For some chemicals, the levels found in the fetus are lower compared with maternal measurements. For example, lead is generally present in slightly lower levels in the cord blood relative to maternal blood (227, 283) . Lower levels of PFAS are also generally found in cord blood compared with maternal blood (118, 124, 128, 129) . Placental transfer of PFAS depends on the length of the carbon chain (2, 3): shorter chain PFAS transferred more readily to cord blood than longer chain PFAS (284, 285) . Cadmium is another example: the placenta seems to be a barrier, with much lower concentration in the cord blood being detected relative to maternal blood (204, 207, 239, 241) .
Studies have reported that PCBs, PFAS, PBDEs, OCPs, phenols such as BPA, TCS, and PBs, phthalates, and phthalate metabolites are detected in breast milk (3) . This indicates that prebirth exposures to the above chemicals and metals can continue to affect the offspring postpartum, via breastfeeding.
ENVIRONMENTAL DISPARITIES AND VULNERABLE POPULATIONS
The potential sources and amount of exposure to toxic chemicals are not the same for everyone. Women and men of reproductive age can encounter toxic chemicals at home, in the community, and in the workplace. Communities and individuals vary in their vulnerability and in their risk for exposure (5) . The amount, duration, and cumulative risk of exposure can depend on social, economic, geographic, occupational, medical, and genetic factors (286) .
Exposure to toxic environmental chemicals and related health outcomes are inequitably distributed among populations within countries and between countries. In the United States, researchers and policy makers have identified a higher frequency and magnitude of exposures to environmental stressors in communities of color and low-income communities (287, 288) . In addition, the consequences of exposure to toxic chemicals-including morbidity and mortality, loss of family income and productivity, and environmental degradation-are disproportionately borne by people with low incomes (289) . For example, lower-income, ethnically diverse pregnant women in California were shown to have the highest level of PBDEs among pregnant women worldwide, mainly owing to geography (e.g., California's unique furniture flammability standards) and socioeconomic status (134) . This combination and potential interaction of elevated environmental hazard exposures, on the one hand, and socioeconomic stressors, on the other, have been described as a form of ''double jeopardy'' (287, 288) .
Occupation can also add additional risk of exposure to toxic chemicals disparities, which in turn impacts risk. For example, women employed as cosmetologists and manicurists are exposed to higher levels of volatile solvents (e.g., formaldehyde, methacrylates, acetone, and toluene), plasticizers (e.g., dibutyl phthalates), and other toxic substances. Pregnant women who worked as cashiers had the highest urinary BPA concentrations (253) . A recent study found that women in the nail and hair care industry were at higher risk of adverse birth outcomes (290) . Farm workers and their families are also at higher risk of exposure to pesticides, with potential adverse reproductive and developmental outcomes (Table 1) (291) .
Even after decades of basic science research and public health initiatives, disparities in pregnancy outcomes, such as preterm birth, remain relatively unchanged. Factors that underpin the disparity are elusive and likely derived in part from complex interactions between social, biologic, and environmental factors including social inequality, genetics, neighborhood-level exposures, roles of infection and inflammation, and preconception health differentials. Better characterizing exposures has been recognized as a need in health disparities research and will provide important information in understanding the cumulative impacts of environmental and social stressors and promoting targeted policies to address these impacts (292) .
FUTURE DIRECTIONS Nontargeted Screening for Novel Chemicals
The chemicals discussed in the present review are merely the tip of the iceberg. There are tens of thousands of chemicals that we may be in contact with but know little or nothing about. Conventional studies used targeted approaches whereby the list of chemical analytes being measured is chosen a priori. There is research need to identify the ''unknown'' chemicals for future biomonitoring that are prevalent in and could potentially pose harm to the human body, using novel methods (293) such as nontargeted screening (publication in preparation).
Cumulative Effects of Multiple Chemical Exposures
Because of the wide application of various environmental chemicals, pregnant women are not exposed to a single chemical or a single class of chemicals, but rather a cocktail of chemicals from different classes. Research finds that simultaneous exposure to multiple chemicals can have an additive or synergistic effect on health, particularly for the same adverse health outcome (294) (295) (296) (297) (298) . Analysis conducted on one chemical at a time is likely to underestimate its potential health effect in the presence of other chemicals. Thus, an increasing number of studies have measured cumulative exposures to multiple chemical classes. A recent review suggests that among those studies of North American and European populations that had measured multiple chemical classes, few have attempted to capture a complete picture across classes and biological matrices (3). Certain classes are frequently measured simultaneously and in a single matrix (maternal urine or maternal serum): nonpersistent phenols and phthalates are often measured in urine, whereas persistent chemicals such as PFAS, PBDEs, PCBs, and OCPs are commonly measured in serum (3) . Epidemiologic studies trying to examine the health effect of joint exposure to different chemicals are limited, possibly owing to a high cost for multiple measurements and limited sample size. Cumulative risk assessment of multiple chemicals and other environmental stressors needs to account for the possible compounded effects on the outcomes of concern, as the appropriate statistical models become available. Meanwhile, more educational efforts are needed to reduce the cumulative chemical exposure load currently experienced by pregnant women (3).
Paternal Exposure
Although the present review focuses on maternal exposure, paternal exposure to environmental chemicals also plays a critical role in the health of next generations. Especially for persistent chemicals like PCBs, PBDEs, and lead, fetal exposure can be a result of parental exposures before conception. Paternal lead exposure was found to affect the development of newborns (299) . Paternal exposures may contribute to fetal risk through mutagenic and epigenetic mechanisms involving the sperm; and the chemical could also be carried in semen, leading to fetal exposure after intercourse (300) (301) (302) .
Interactions between Gene and Environmental Chemicals
Humans can vary in their susceptibility to the adverse effects of toxic chemicals owing to genetic variability (303) . For example, one study found that higher maternal blood levels of b-hexachlorocyclohexane, an OCP, is associated with increased risk of idiopathic preterm delivery in women with GSTM1 null polymorphisms, because they lack activity of the enzymes responsible for detoxification of xenobiotics (304) . Some genetic variant may also modify placental transfer of chemicals, leading to differential levels of fetal exposure. For example, a maternal iron metabolism genotype was found to be a modifier of placental lead transfer in the US population: infants born to mothers with HFE C282Y gene variant have lower cord blood level concentrations relative to those born to mothers who were wild-type (prevailing among individuals in natural conditions) (192) .
The relation between genetic profile and the external environment in affecting human health is not unidirectional but bidirectional. Toxic environmental exposure could also induce changes in gene regulatory mechanisms that correlate strongly with disease etiology (e.g., cancer and infertility) (305) . For example, PCBs may cause mutations in p53 and K-ras oncogenes and represent risk factors for colorectal and pancreatic cancers (306, 307) . The inclusion of geneenvironmental interaction in risk assessment may help identify and thus safeguard vulnerable populations.
RECOMMENDATION FOR PREVENTION
In clinical settings, obstetricians and gynecologists can provide authoritative and science-based guidance on how to avoid potentially adverse exposures (82) . They are also uniquely poised to intervene to prevent harm before and during pregnancy, which is a critical window of human development (308) . In 2015 the International Federation of Gynecology and Obstetrics (FIGO) released an opinion article on reproductive health impacts of exposure to toxic environmental chemicals, in which FIGO joins the American College of Obstetrics and Gynecology/American Society for Reproductive Medicine, the Royal College of Obstetricians and Gynecologists, the Endocrine Society, and the Society of Obstetricians and Gynecologists of Canada in ''urging reproductive health professionals including obstetricians, gynecologists, midwives, nurses, women's health nurses practitioners and others to take timely action to prevent exposure to toxic environmental chemicals'' (5). Clinicians can adopt several tactics to incorporate environmental health into their patient-centered care, including [1] becoming knowledgeable about toxic environmental agents that are endemic to their specific geographic area, [2] intervening as early as possible (before conception and during pregnancy), [3] taking an exposure history (especially occupational exposures), [4] providing anticipatory guidance on how to make healthier choices and avoid toxic exposures at home, in the community, and at work, and [5] reporting identified hazards. Detailed strategies and useful resources have been summarized elsewhere (1, 82, 308) .
The role of reproductive health professionals in preventing harmful environmental exposures extends beyond the clinical setting. Advancing society-wide and preventionoriented policy actions is essential for reducing toxic exposures to pregnant women and other vulnerable populations because many exposures are beyond individual's control (i.e., from air and water) (82) . To this end, clinicians play a crucial role in, for instance, initiating institutional-level interventions in support of a healthy food system and engaging in reducing pesticide use in institutional pest-control policies (82) and many more policy settings, including through their own professional organizations.
Understanding the sources and extent of exposures to environmental chemicals is a critical element in the efforts of reproductive health professionals to identify and prevent harmful chemical exposures to their patients and the population. In conclusion, to translate science into healthier pregnancy, healthier children, and healthy future generations, efforts are needed in advancing scientific research on characterizing chemical exposure in pregnant women and its health impact, synthesizing evidence to develop recommendations for prevention using systematic methods (309) , and promoting policy change.
